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Understanding and linking at the molecular level a disease phenotype to a specific genotype often requires
going through a protein structure and function. In this issue of Structure, Gao et al. (2015) perform large scale
analysis of available sequences and structural data for more than 6000 mutants representing more than 600
proteins to uncover some interesting structural effects of disease-associated mutations.One of the more significant promises
of structural biology is to provide rational
explanation to statistical correlations
found in genotype-phenotype databases.
These types of correlations are of partic-
ular interest for point mutations in human
DNA and protein molecules and diseases.
Nevertheless, the logical leap between
a molecular variation and a disease is
huge. The statistical analyses alone do
not lead to a better understanding of the
phenomenon or how to (rationally) treat
it. It is therefore no wonder that a number
of investigations were carried out to better
analyze mutational effects using the infor-
mation embedded in protein structures.
These studies include the pioneering
investigation by Wang and Moult (2001)
and the follow up research by Steward
et al. (2003). However, by the time these
investigations were carried out, the avail-
able statistics were limited. This reduces
confidence in some of the conclusions
and also makes it difficult to detect more
subtle relationships between mutations,
diseases, and protein structures that
pass undetected in smaller samples.
The study by Gao et al. (2015) in this
issue significantly extends the prior
studies. The most straightforward exten-
sion is the use of a much larger data set.
It also cleverly exploits accurate algo-
rithms for prediction of protein functionto further enhance the data at hand. The
current study examines 6,025 mutations
in 624 proteins—a set that is large enough
to obtain a statistically significant signal
for a number of queries. However, the
present investigation is going beyond
this obvious (but technically challenging)
extension of a use of a larger set and
provides novel non-trivial observations
that are likely to be re-examined and
expanded in future studies.
Some expectations and hypotheses of
how mutations impact protein functions
in living systems were, of course, known
for a long time; for example, one possible
effect of a mutation is the reduction of the
stability of the protein structure. Such re-
ductions frequently occur when a muta-
tion is at the hydrophobic core of the pro-
tein. It limits the ability of the protein to
function, which may result in a disease.
The reverse is also true. If the mutation
is at the surface of the protein far away
from active sites, then the impact on func-
tion is expected to be small. Both of these
intuitive conjectures are supported by the
statistical analysis of Gao et al. (2015),
which is reassuring. These are far from
trivial conjectures, because the path
from a change of a single molecule to a
large-scale (macroscopic) disease of a
living being is complex and includes
many temporal and spatial scales. ManyStructure 23, July 7, 2015factors that we do not fully understand
are likely to be involved. This statistically
highly significant result reaffirms the great
promise of rational molecular medicine.
It is also gratifying that in addition to
confirming common beliefs, the present
study reveals novel harmful mutations of
a type that was not previously considered.
The study illustrates that mutations near
(but not at) protein-protein interaction
(PPI) sites are also likely to lead to dis-
eases. This unexpected observation may
be related to activated and ligand-binding
sites proximate to the PPI. It will further
strengthen the link between structural
biology and rapid sequence analyses of
genomes and genome variations. It is
therefore likely that the expected further
increase in the number of sequences
and structureswill be followed up by addi-
tional statistical analyses and new in-
sights into molecular diseases and how
to address them.REFERENCES
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